Citius Pharmaceuticals, Inc. Accrued Liabilities, Current
Citius Pharmaceuticals, Inc. (CTXR) had Accrued Liabilities, Current of $25.91 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Accrued Liabilities, Current $25.91M.
- 2026-03-31: Accrued Liabilities, Current $24.14M.
- 2025-12-31: Accrued Liabilities, Current $4.69M.
- 2025-09-30: Accrued Liabilities, Current $4.19M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2026-06-30 | $25.91M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $24.14M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $4.69M 10-Q · filed 2026-02-13 |
| 2025-09-30 | $4.19M 10-Q · filed 2026-08-14 |
| 2025-06-30 | $8.52M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $8.78M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $6.24M 10-Q · filed 2025-02-14 |
| 2024-09-30 | $17.03K 10-K · filed 2025-12-23 |
| 2024-06-30 | $550.49K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $151.20K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $276.90K 10-Q · filed 2024-02-14 |
| 2023-09-30 | $476.30K 10-K · filed 2024-12-27 |
| 2023-06-30 | $892.87K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $2.25M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $690.40K 10-Q · filed 2023-02-10 |
| 2022-09-30 | $1.41M 10-K · filed 2023-12-29 |
| 2022-06-30 | $1.30M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $1.34M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $3.14M 10-Q · filed 2022-02-10 |
| 2021-09-30 | $621.96K 10-K · filed 2022-12-22 |
| 2021-06-30 | $366.74K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $240.61K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $252.48K 10-Q · filed 2021-02-11 |
| 2020-09-30 | $164.04K 10-K · filed 2021-12-15 |
| 2020-06-30 | $163.86K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $149.99K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $209.12K 10-Q · filed 2020-02-13 |
| 2019-09-30 | $246.22K 10-K · filed 2020-12-16 |
| 2019-06-30 | $158.22K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $175.99K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $200.43K 10-Q · filed 2019-02-14 |
| 2018-09-30 | $181.66K 10-K · filed 2019-12-16 |
| 2018-06-30 | $115.34K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $142.94K 10-Q · filed 2018-05-11 |
| 2017-12-31 | $616.21K 10-Q · filed 2018-02-14 |
| 2017-09-30 | $560.92K 10-K · filed 2018-12-11 |
| 2017-06-30 | $654.95K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $1.86M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $1.85M 10-Q · filed 2017-02-14 |
| 2016-09-30 | $958.10K 10-K · filed 2017-12-13 |
| 2016-06-30 | $585.03K 10-Q · filed 2016-08-15 |
| 2016-03-31 | $1.00M 10-Q · filed 2016-05-20 |
| 2015-12-31 | $535.00K 10-Q · filed 2016-02-12 |
| 2015-09-30 | $8.26K 10-K · filed 2016-12-23 |
| 2015-06-30 | $26.52K 10-Q · filed 2015-08-13 |
| 2015-03-31 | $8.17K 10-Q · filed 2015-05-13 |
| 2014-12-31 | $520.00 10-Q · filed 2015-02-17 |
| 2014-09-30 | $60.32K 10-K · filed 2015-12-14 |
| 2013-12-31 | $3.55K 10-KT · filed 2014-12-29 |
| 2013-09-30 | $0.00 10-K · filed 2014-02-06 |
| 2013-06-30 | $3.95K 10-Q · filed 2013-09-18 |
| 2013-03-31 | $3.95K 10-Q · filed 2013-05-13 |
| 2012-12-31 | $3.95K 10-Q · filed 2013-02-08 |
| 2012-09-30 | $4.15K 10-K · filed 2014-02-06 |
| 2012-06-30 | $4.15K 10-Q · filed 2012-08-17 |
| 2012-03-31 | $3.95K 10-Q · filed 2012-05-11 |
| 2011-12-31 | $3.95K 10-Q · filed 2012-02-14 |
| 2011-09-30 | $3.95K 10-K · filed 2013-01-15 |
| 2011-06-30 | $6.45K 10-Q · filed 2011-08-26 |
| 2010-09-30 | $0.00 10-Q · filed 2011-08-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |